Tuesday Update: Key Details Now On Nasdaq Idea (NMTC)
The opening bell fast approaches, so let's skip the pleasantries.
NMTC needs to be back on radar this morning and for good reason.
Yesterday, slowly but surely grinded to a strong close yesterday at its high of day of $1.90.
But that wasn't all. Shortly after close, NMTC even climbed up to as high as $1.92.
Could we see a continued move today?
NMTC keeps chugging along this morning.
Remember, a Q3 financials announcement looms this week and that could become a true, short term catalyst for this Nasdaq idea.
And there could be a ton of potential support as NMTC recently moved above 3 key lines of potential support (50-Day Simple Moving Average, 200-Day Simple Moving Average, and its 13-Day Exponential Moving Average).
Read my initial NMTC report below now and get this Nasdaq profile pulled up quickly again today.
Time is ticking so let's not waste a second.
But first let's take a trip down memory lane...
AVCO was brought to your attention after it closed Wednesday's session at $.645.
When Thursday's session came around, it went on an absolute tear running to a 4+ month high of $.8050.
With that run, AVCO became my latest short term stud running approximately 24% in the blink of an eye.
Seeing how hot that healthcare profile came out, I decided to stick to the same industry for this new breakout idea.
Let me ask, what do you know about the future $13.6Bn neurostimulation devices market?
If it's not much, don't worry. All you need to soak in is the sheer size of this potential market by 2027 and let me fill in the details.
I've uncovered a company that is forwarding their game-changing tech to become an industry disruptor, but for now has flown well under Wall Street's radar.
With bullish technical indicators, an explosive chart history, huge August news, and a low float, it may be no better time than now to get this Nasdaq profile on your screen as it recently pushed above now key support lines including its:
- 50-Day Simple Moving Average (SMA)
- 13-Day Exponential Moving Average (EMA)
And if potential resistance breaks down at the 200-Day SMA level, which this profile has been battling mightily, all bets could be off on the vertical chart march this breakout idea could make.
Ready for the goods? Here it is:
*NeuroOne Medical Technologies Corporation (NMTC)*
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
And right now, NMTC has 5 potential driver indicators to immerse yourself in:
No. 1 - Low Float Volatility Could Grab Hold
No. 2 - Accelerated Milestone Payment Accomplishes Multiple Objectives (Huge News)
No. 3 - Triggered Technicals Could Signal A Near Term Vertical Chart Move
No. 4 - Another Game-Changing Milestone With First Evo sEEG Electrode Clinical Case
No. 5 - A Chart History Of Explosive Short Term Runs
But more on those in a second...
Evo® Cortical Electrode
Cortical or subdural electrodes are used in electrocorticography (ECoG) or intracranial electroencephalography (iEEG) surgeries to monitor, record and stimulate the surface of the brain for up to 30 days. The company's Evo cortical electrode portfolio consists of various contact configurations of strip and grid electrodes. (Rx only)